SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression

被引:20
|
作者
Jaiswal, AS [1 ]
Narayan, S [1 ]
机构
[1] Univ Florida, Coll Med, Dept Anat & Cell Biol, UF Shands Canc Ctr, Gainesville, FL 32610 USA
关键词
DNA alkylation; p53; phosphorylation; DNA-binding; p21 gene regulation;
D O I
10.1016/S0027-5107(01)00296-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
p53 is an important player in the cellular response to genotoxic stress whose functions are regulated by phosphorylation of a number of serine and threonine residues. Phosphorylation of p53 influences its DNA-binding and gene regulation activities. This study examines p53 phosphorylation in HCT-116 (MMR-deficient) and HCT-116+ch3 (MMR-proficient) human colon cancer cells treated with a S(N)2 DNA-alkylating agent, methylmethane sulfonate (MMS). MMS induces phosphorylation of p53 on Ser15 and Ser392 in a dose- and time-dependent manner. MMS-induced p53 phosphorylation is independent of DNA mismatch repair (MMR) activity. Nuclear extracts from MMS-treated HCT-116 cells had higher p21(WAF1/Cip1) (p21) promoter DNA-binding activity in vitro opposed to untreated cells. After MMS treatment, the activation of the cloned p21 promoter in a transient transfection assay and endogenous p21 mRNA levels in HCT-116(p53(+/+)) versus HCT-116(p53(-/-)) cells increased, which correlates with an increased levels of phospho-p53(Ser15) and phospho-p53(Ser392). These results suggest that S(N)2 DNA-alkylating agent-induced phosphorylation of p53 on Ser15 and Ser392 increases its DNA-binding properties to cause an increased expression of p21 that may play a role in cell cycle arrest and/or apoptosis of HCT-116 cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [41] MSK1 functions as a transcriptional coactivator of p53 in the regulation of p21 gene expression
    Ahn, Jihye
    Lee, Jin Gyeong
    Chin, Chuevin
    In, Suna
    Yang, Aerin
    Park, Hee-Sung
    Kim, Jaehoon
    Park, Jeong Hyeon
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : 1 - 12
  • [42] Ovarian expression of p53 and p21 apoptosis regulators in γ-irradiated mice
    Lee, Chang Joo
    Kim, Heung-Tae
    Song, Kang Won
    Kim, Sang Soo
    Park, Ho Hyun
    Yoon, Yong-Dal
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2008, 75 (02) : 383 - 391
  • [43] p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
    Qin, LF
    Ng, IOL
    Fan, ST
    Ng, M
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (04) : 424 - 428
  • [44] Increase in p21 expression independent of the p53 pathway in bleomycin-induced lung fibrosis
    Blundell, R
    Kaminski, N
    Harrison, D
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2004, 77 (03) : 231 - 237
  • [45] P53, p21, and p73 gene polymorphisms in gastric carcinoma in Japan
    Shirai, Osamu
    Ohmiya, Naoki
    Taguchi, Ayurnu
    Itoh, Akihiro
    Hirooka, Yoshiki
    Niwa, Yasumasa
    Maeda, Osamu
    Ando, Takaftimi
    Goto, Hiderm
    GASTROENTEROLOGY, 2008, 134 (04) : A609 - A609
  • [46] p53 interferes with HRX fusion protein activation of the p21 promoter.
    Payne, JM
    Tkachuk, DC
    BLOOD, 1999, 94 (10) : 178B - 178B
  • [47] Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21
    Nakanishi, Y
    Pei, XH
    Takayama, K
    Bai, F
    Izumi, M
    Kimotsuki, K
    Inoue, K
    Minami, T
    Wataya, H
    Hara, N
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (06) : 747 - 754
  • [48] Arsenic trioxide-induced apoptosis in TM4 Sertoli cells: The potential involvement of p21 expression and p53 phosphorylation
    Kim, Yoon-Jae
    Chung, Jin-Yong
    Lee, Seung Gee
    Kim, Ji Young
    Park, Ji-Eun
    Kim, Won Rok
    Joo, Bo Sun
    Han, Seong Ho
    Yoo, Ki Soo
    Yoo, Young Hyun
    Kim, Jong-Min
    TOXICOLOGY, 2011, 285 (03) : 142 - 151
  • [49] p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma
    Hamada, M
    Naomoto, Y
    Shirakawa, Y
    Yamatsuji, T
    Noma, K
    Motoki, T
    Nobuhisa, T
    Okawa, T
    Haisa, M
    Gunduz, M
    Matsuoka, J
    Tanaka, N
    ONCOLOGY REPORTS, 2004, 11 (01) : 57 - 63
  • [50] Requirement for p53 and p21 to sustain G2 arrest after DNA damage
    Bunz, F
    Dutriaux, A
    Lengauer, C
    Waldman, T
    Zhou, S
    Brown, JP
    Sedivy, JM
    Kinzler, KW
    Vogelstein, B
    SCIENCE, 1998, 282 (5393) : 1497 - 1501